Peter Wijngaard bought HEPA once, on Dec 18, 2020
Director at Hepion Pharmaceuticals, Inc.
SEC CIK 0001778501 · Filings on SEC.gov ↗
$38KBought
$0Sold
Dec 21Last buy
Peter Wijngaard's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
1 filing since Dec 2020, newest first
Filings come from SEC EDGAR. Not investment advice.